Fluorescence in situ hybridization in hematology

被引：0
作者：
Milosevic, Ivana [1 ]
Popovic, Stevan [1 ]
Urosevic, Ivana [1 ]
机构：
[1] Klin Ctr Vojvodine, Klin Hematol, Novi Sad 21000, Serbia
来源：
VOJNOSANITETSKI PREGLED | 2012年 / 69卷 / 11期
关键词：
chromosome aberrations; chromosome disorders; cytogenetics; in situ hybridization; fluorescence; hematologic neoplasms; CHRONIC LYMPHOCYTIC-LEUKEMIA; RECURRING CYTOGENETIC ABNORMALITIES; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; MULTIPLE-MYELOMA; GENETIC ABNORMALITIES; CELL LYMPHOMA; CHROMOSOMAL-ABNORMALITIES; MYELODYSPLASTIC SYNDROMES; PROGNOSTIC-SIGNIFICANCE;
D O I：
10.2298/VSP1211986M
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：986 / 993
页数：8
相关论文
共 53 条
  • [1] Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
    Alizadeh, AA
    Eisen, MB
    Davis, RE
    Ma, C
    Lossos, IS
    Rosenwald, A
    Boldrick, JG
    Sabet, H
    Tran, T
    Yu, X
    Powell, JI
    Yang, LM
    Marti, GE
    Moore, T
    Hudson, J
    Lu, LS
    Lewis, DB
    Tibshirani, R
    Sherlock, G
    Chan, WC
    Greiner, TC
    Weisenburger, DD
    Armitage, JO
    Warnke, R
    Levy, R
    Wilson, W
    Grever, MR
    Byrd, JC
    Botstein, D
    Brown, PO
    Staudt, LM
    [J]. NATURE, 2000, 403 (6769) : 503 - 511
  • [2] CLINICAL DETECTION OF BCR-ABL FUSION BY INSITU HYBRIDIZATION IN CHRONIC MYELOGENOUS LEUKEMIA
    AMIEL, A
    YARKONI, S
    FEJGIN, M
    GABER, E
    NAGLER, A
    MANOR, Y
    LISHNER, M
    [J]. CANCER GENETICS AND CYTOGENETICS, 1993, 65 (01) : 32 - 34
  • [3] Prognostic impact of acute myeloid leukemia classification - Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival
    Arber, DA
    Stein, AS
    Carter, NH
    Ikle, D
    Forman, SJ
    Slovak, ML
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (05) : 672 - 680
  • [4] t(11;18)(q21;q21) is the most common translocation in MALT lymphomas
    Auer, IA
    Gascoyne, RD
    Connors, JM
    Cotter, FE
    Greiner, TC
    Sanger, WG
    Horsman, DE
    [J]. ANNALS OF ONCOLOGY, 1997, 8 (10) : 979 - 985
  • [5] Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
    Avet-Loiseau, Herve
    Attal, Michel
    Moreau, Philippe
    Charbonnel, Catherine
    Garban, Frederic
    Hulin, Cyrille
    Leyvraz, Serge
    Michallet, Mauricette
    Yakoub-Agha, Ibrahim
    Garderet, Laurent
    Marit, Gerald
    Michaux, Lucienne
    Voillat, Laurent
    Renaud, Marc
    Grosbois, Bernard
    Guillerm, Gaelle
    Benboubker, Lotfi
    Monconduit, Mathieu
    Thieblemont, Catherine
    Casassus, Philippe
    Caillot, Denis
    Stoppa, Anne-Marie
    Sotto, Jean-Jacques
    Wetterwald, Marc
    Dumontet, Charles
    Fuzibet, Jean-Gabriel
    Azais, Isabelle
    Dorvaux, Veronique
    Zandecki, Marc
    Bataille, Regis
    Minvielle, Stephane
    Harousseau, Jean-Luc
    Facon, Thierry
    Mathiot, Claire
    [J]. BLOOD, 2007, 109 (08) : 3489 - 3495
  • [6] The Myelodysplastic Syndromes: Morphology, risk assessment, and clinical management (2002)
    Bennett, JM
    Kouides, PA
    Forman, SJ
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2002, 76 (Suppl 2) : 228 - 238
  • [7] Incidence and prognostic significance of karyotype abnormalities in de novo primary myelodysplastic syndromes: a study on 331 patients from a single institution
    Bernasconi, P
    Klersy, C
    Boni, M
    Cavigliano, PM
    Calatroni, S
    Giardini, I
    Rocca, B
    Zappatore, R
    Caresana, M
    Quarna, J
    Lazzarino, M
    Bernasconi, C
    [J]. LEUKEMIA, 2005, 19 (08) : 1424 - 1431
  • [8] Translocations involving c-myc and c-myc function
    Boxer, LM
    Dang, CV
    [J]. ONCOGENE, 2001, 20 (40) : 5595 - 5610
  • [9] New highly sensitive fluorescence in situ hybridization method to detect PML/RARA fusion in acute promyelocytic leukemia
    Brockman, SR
    Paternoster, SF
    Ketterling, RP
    Dewald, GW
    [J]. CANCER GENETICS AND CYTOGENETICS, 2003, 145 (02) : 144 - 151
  • [10] Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy
    Cortes, JE
    Talpaz, M
    Giles, F
    O'Brien, S
    Rios, MB
    Shan, J
    Garcia-Manero, G
    Faclerl, S
    Thomas, DA
    Wierda, W
    Ferrajoli, A
    Jeha, S
    Kantarjian, HM
    [J]. BLOOD, 2003, 101 (10) : 3794 - 3800
123456